berberine glp-1 agonist as a multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence | European Journal of Medical Research Is Berberine a GLP-1 Receptor
Description
Diab Obes
The rising prevalence of type 2 diabetes and obesity in these countries is increasing demand for effective GLP-1 agonist therapies
References Abushanab D, Mohammed HR, Abdul Rouf PV, Thomas B, Al-Badriyeh D, Elkassem W, Al-Mohannadi H, Hanssens Y, Khan S, Mohammed S et al
Meditation, yoga, or even a daily walk can help keep stress in check
